
Opinion|Videos|January 7, 2026
Closing Thoughts from the Experts
This final segment consists of expert clinicians offering key takeaways to help pharmacists prepare for potential approvals and integrate new TNBC therapies into practice.
Advertisement
Episodes in this series

An expert pharmacist and physician offer their main takeaways from the recent clinical trial data in TNBC. Clinical pearls for pharmacists are offered that will help prepare them for potential approval of these pharmacotherapies.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Trending on Pharmacy Times
1
FDA Notifies Flu Vaccine Makers to Add Warning for Increased Febrile Seizure Risk in Young Children Day Following Vaccination
2
In 2026, Pharmacists Will Be Driving Change Across the Care Continuum
3
Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events
4
AI-Powered Digital Twins Offer a New Window Into Tumor Metabolism in Brain Cancer
5













































































































































































































